Differences in clinical characteristics and cardiovascular disease risk prediction among Chinese women with polycystic ovary syndrome phenotypes: a cross-sectional study - Takeaways - MDSpire

Differences in clinical characteristics and cardiovascular disease risk prediction among Chinese women with polycystic ovary syndrome phenotypes: a cross-sectional study

  • By

  • Ziye Gong

  • Danyang Li

  • Xuan Li

  • Jinjin Tian

  • Jing Guo

  • Yuying Zhao

  • Yin Lu

  • Shan Gao

  • Ming Li

  • April 10, 2026

  • 0 min

Share

  • 1

    The study analyzed 206 Chinese women with PCOS, classifying them into four phenotypes based on the Rotterdam criteria.

  • 2

    Phenotypes A, B, and C exhibited significantly higher BMI, blood pressure, and CVD risk compared to phenotype D.

  • 3

    Lifetime CVD risk scores were notably higher in phenotypes A, B, and C, with values of 15.55%, 17.65%, and 17.30%, respectively.

  • 4

    BMI, HOMA-IR, and uric acid levels significantly mediated the relationship between PCOS phenotypes and CVD risk.

  • 5

    Regular CVD risk assessments are recommended for women with different PCOS phenotypes to guide individualized treatment strategies.

Original Source(s)

Differences in clinical characteristics and cardiovascular disease risk prediction among Chinese women with polycystic ovary syndrome phenotypes: a cross-sectional study

  • by Ziye Gong, Danyang Li, Xuan Li, Jinjin Tian, Jing Guo, Yuying Zhao, Yin Lu, Shan Gao, Ming Li

  • April 10, 2026

Related Content

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications

Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study